Predictive factors of isolated tumor cells and micrometastases in axillary lymph nodes in breast cancer
Abstract Introduction Since the introduction of the sentinel lymph node biopsy (SLNB) in patients with breast cancer, micrometastases and isolated tumor cells are detected frequently in the SLN. As such, they offer an opportunity to study the development of regional metastases in breast cancer. Pati...
Gespeichert in:
Veröffentlicht in: | Breast (Edinburgh) 2013-10, Vol.22 (5), p.748-752 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 752 |
---|---|
container_issue | 5 |
container_start_page | 748 |
container_title | Breast (Edinburgh) |
container_volume | 22 |
creator | Madsen, Eva V.E Elias, Sjoerd G van Dalen, Thijs van Oort, Pouline M.P van Gorp, Joost Gobardhan, Paul D Bongers, Vivian |
description | Abstract Introduction Since the introduction of the sentinel lymph node biopsy (SLNB) in patients with breast cancer, micrometastases and isolated tumor cells are detected frequently in the SLN. As such, they offer an opportunity to study the development of regional metastases in breast cancer. Patients and methods Between June 1999 and November 2010 1418 patients with cT1-2N0 breast cancer underwent SLNB. Primary tumor characteristics and information regarding regional lymph node involvement were collected prospectively. Patients were categorized into four levels of lymph node involvement: pN0, pN0(i+), pN1mi and pN ≥ 1a. An univariate analysis and a binary logistic regression analysis were performed to assess the relation between patient- and tumor characteristics and lymph node involvement. Results Increasing tumor size and younger age were associated with a higher risk of pN1mi and pN ≥ 1a and a lower chance of pN0 and pN0(i+). Triple negative molecular subtype was associated with a decreased risk of pN1mi and pN ≥ 1a. Tumor size was positively related to overall occurrence of regional lymph node metastases in a linear manner. Conclusion Patients with larger tumors, no triple negative disease, and younger age showed a decreased chance of both pN0 and pN0(i+) and an increased risk of both pN1mi and pN ≥ 1a. There seems to be a gradual shift in risk pattern from pN0 to pN0(i+) to pN1mi and to pN ≥ 1a-disease. The presence of the smallest metastases remained fairly constant over time when compared to macrometastases. This constant presence suggests that the risk of seeding and outgrowth of metastases remains constant over time. |
doi_str_mv | 10.1016/j.breast.2012.12.013 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1433516895</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960977612002573</els_id><sourcerecordid>1433516895</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-141bb2c83ac07fda4b5e0ef7c021e0722557579f9db15865a4983363bc09fd5b3</originalsourceid><addsrcrecordid>eNqFkVFrFTEQhYMo9rb6D0Ty6MteJ8lms_siSGm1UFBofQ7ZZFZz3d1ck2zp_fdm2eqDL8JAIJwzM-cbQt4w2DNgzfvDvo9oUt5zYHxfCph4RnZMCl4JaOE52UHXQNUp1ZyR85QOANCJpn1JzrgQTEADO_L9a0TnbfYPSAdjc4iJhoH6FEaT0dG8TCFSi-OYqJkdnbyNYcJcBpuEifqZmkc_jiae6Hiajj_oHNz2v61HrZktxlfkxWDGhK-f3gvy7frq_vJzdfvl083lx9vK1kzlitWs77lthbGgBmfqXiLgoCxwhqA4l1JJ1Q2d65lsG2nqrhWiEb2FbnCyFxfk3db3GMOvBVPWk0_r-mbGsCTNaiEka9pOFmm9SUuilCIO-hj9VIJoBnpFrA96y6BXxLpUQVxsb58mLP2E7q_pD9Mi-LAJsOR88Bh1sh4LBOcj2qxd8P-b8G8DO_rZWzP-xBOmQ1jiXBhqplMx6Lv1zOuVGQfgUgnxG7K0pKs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1433516895</pqid></control><display><type>article</type><title>Predictive factors of isolated tumor cells and micrometastases in axillary lymph nodes in breast cancer</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Madsen, Eva V.E ; Elias, Sjoerd G ; van Dalen, Thijs ; van Oort, Pouline M.P ; van Gorp, Joost ; Gobardhan, Paul D ; Bongers, Vivian</creator><creatorcontrib>Madsen, Eva V.E ; Elias, Sjoerd G ; van Dalen, Thijs ; van Oort, Pouline M.P ; van Gorp, Joost ; Gobardhan, Paul D ; Bongers, Vivian</creatorcontrib><description>Abstract Introduction Since the introduction of the sentinel lymph node biopsy (SLNB) in patients with breast cancer, micrometastases and isolated tumor cells are detected frequently in the SLN. As such, they offer an opportunity to study the development of regional metastases in breast cancer. Patients and methods Between June 1999 and November 2010 1418 patients with cT1-2N0 breast cancer underwent SLNB. Primary tumor characteristics and information regarding regional lymph node involvement were collected prospectively. Patients were categorized into four levels of lymph node involvement: pN0, pN0(i+), pN1mi and pN ≥ 1a. An univariate analysis and a binary logistic regression analysis were performed to assess the relation between patient- and tumor characteristics and lymph node involvement. Results Increasing tumor size and younger age were associated with a higher risk of pN1mi and pN ≥ 1a and a lower chance of pN0 and pN0(i+). Triple negative molecular subtype was associated with a decreased risk of pN1mi and pN ≥ 1a. Tumor size was positively related to overall occurrence of regional lymph node metastases in a linear manner. Conclusion Patients with larger tumors, no triple negative disease, and younger age showed a decreased chance of both pN0 and pN0(i+) and an increased risk of both pN1mi and pN ≥ 1a. There seems to be a gradual shift in risk pattern from pN0 to pN0(i+) to pN1mi and to pN ≥ 1a-disease. The presence of the smallest metastases remained fairly constant over time when compared to macrometastases. This constant presence suggests that the risk of seeding and outgrowth of metastases remains constant over time.</description><identifier>ISSN: 0960-9776</identifier><identifier>EISSN: 1532-3080</identifier><identifier>DOI: 10.1016/j.breast.2012.12.013</identifier><identifier>PMID: 23313060</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Adult ; Age Factors ; Aged ; Aged, 80 and over ; Axilla ; Breast cancer ; Breast Neoplasms - pathology ; Breast Neoplasms - surgery ; Female ; Hematology, Oncology and Palliative Medicine ; Humans ; Isolated tumor cells ; Lymph node metastases ; Lymph Nodes - pathology ; Lymphatic Metastasis ; Micrometastases ; Middle Aged ; Neoplasm Micrometastasis - pathology ; Neoplasm Staging ; Predictive factors ; Risk Assessment ; Risk Factors ; Sentinel Lymph Node Biopsy ; Triple Negative Breast Neoplasms - pathology ; Tumor Burden ; Tumor characteristics ; Young Adult</subject><ispartof>Breast (Edinburgh), 2013-10, Vol.22 (5), p.748-752</ispartof><rights>Elsevier Ltd</rights><rights>2012 Elsevier Ltd</rights><rights>Copyright © 2012 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-141bb2c83ac07fda4b5e0ef7c021e0722557579f9db15865a4983363bc09fd5b3</citedby><cites>FETCH-LOGICAL-c417t-141bb2c83ac07fda4b5e0ef7c021e0722557579f9db15865a4983363bc09fd5b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.breast.2012.12.013$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23313060$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Madsen, Eva V.E</creatorcontrib><creatorcontrib>Elias, Sjoerd G</creatorcontrib><creatorcontrib>van Dalen, Thijs</creatorcontrib><creatorcontrib>van Oort, Pouline M.P</creatorcontrib><creatorcontrib>van Gorp, Joost</creatorcontrib><creatorcontrib>Gobardhan, Paul D</creatorcontrib><creatorcontrib>Bongers, Vivian</creatorcontrib><title>Predictive factors of isolated tumor cells and micrometastases in axillary lymph nodes in breast cancer</title><title>Breast (Edinburgh)</title><addtitle>Breast</addtitle><description>Abstract Introduction Since the introduction of the sentinel lymph node biopsy (SLNB) in patients with breast cancer, micrometastases and isolated tumor cells are detected frequently in the SLN. As such, they offer an opportunity to study the development of regional metastases in breast cancer. Patients and methods Between June 1999 and November 2010 1418 patients with cT1-2N0 breast cancer underwent SLNB. Primary tumor characteristics and information regarding regional lymph node involvement were collected prospectively. Patients were categorized into four levels of lymph node involvement: pN0, pN0(i+), pN1mi and pN ≥ 1a. An univariate analysis and a binary logistic regression analysis were performed to assess the relation between patient- and tumor characteristics and lymph node involvement. Results Increasing tumor size and younger age were associated with a higher risk of pN1mi and pN ≥ 1a and a lower chance of pN0 and pN0(i+). Triple negative molecular subtype was associated with a decreased risk of pN1mi and pN ≥ 1a. Tumor size was positively related to overall occurrence of regional lymph node metastases in a linear manner. Conclusion Patients with larger tumors, no triple negative disease, and younger age showed a decreased chance of both pN0 and pN0(i+) and an increased risk of both pN1mi and pN ≥ 1a. There seems to be a gradual shift in risk pattern from pN0 to pN0(i+) to pN1mi and to pN ≥ 1a-disease. The presence of the smallest metastases remained fairly constant over time when compared to macrometastases. This constant presence suggests that the risk of seeding and outgrowth of metastases remains constant over time.</description><subject>Adult</subject><subject>Age Factors</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Axilla</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - pathology</subject><subject>Breast Neoplasms - surgery</subject><subject>Female</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Isolated tumor cells</subject><subject>Lymph node metastases</subject><subject>Lymph Nodes - pathology</subject><subject>Lymphatic Metastasis</subject><subject>Micrometastases</subject><subject>Middle Aged</subject><subject>Neoplasm Micrometastasis - pathology</subject><subject>Neoplasm Staging</subject><subject>Predictive factors</subject><subject>Risk Assessment</subject><subject>Risk Factors</subject><subject>Sentinel Lymph Node Biopsy</subject><subject>Triple Negative Breast Neoplasms - pathology</subject><subject>Tumor Burden</subject><subject>Tumor characteristics</subject><subject>Young Adult</subject><issn>0960-9776</issn><issn>1532-3080</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkVFrFTEQhYMo9rb6D0Ty6MteJ8lms_siSGm1UFBofQ7ZZFZz3d1ck2zp_fdm2eqDL8JAIJwzM-cbQt4w2DNgzfvDvo9oUt5zYHxfCph4RnZMCl4JaOE52UHXQNUp1ZyR85QOANCJpn1JzrgQTEADO_L9a0TnbfYPSAdjc4iJhoH6FEaT0dG8TCFSi-OYqJkdnbyNYcJcBpuEifqZmkc_jiae6Hiajj_oHNz2v61HrZktxlfkxWDGhK-f3gvy7frq_vJzdfvl083lx9vK1kzlitWs77lthbGgBmfqXiLgoCxwhqA4l1JJ1Q2d65lsG2nqrhWiEb2FbnCyFxfk3db3GMOvBVPWk0_r-mbGsCTNaiEka9pOFmm9SUuilCIO-hj9VIJoBnpFrA96y6BXxLpUQVxsb58mLP2E7q_pD9Mi-LAJsOR88Bh1sh4LBOcj2qxd8P-b8G8DO_rZWzP-xBOmQ1jiXBhqplMx6Lv1zOuVGQfgUgnxG7K0pKs</recordid><startdate>20131001</startdate><enddate>20131001</enddate><creator>Madsen, Eva V.E</creator><creator>Elias, Sjoerd G</creator><creator>van Dalen, Thijs</creator><creator>van Oort, Pouline M.P</creator><creator>van Gorp, Joost</creator><creator>Gobardhan, Paul D</creator><creator>Bongers, Vivian</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20131001</creationdate><title>Predictive factors of isolated tumor cells and micrometastases in axillary lymph nodes in breast cancer</title><author>Madsen, Eva V.E ; Elias, Sjoerd G ; van Dalen, Thijs ; van Oort, Pouline M.P ; van Gorp, Joost ; Gobardhan, Paul D ; Bongers, Vivian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-141bb2c83ac07fda4b5e0ef7c021e0722557579f9db15865a4983363bc09fd5b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult</topic><topic>Age Factors</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Axilla</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - pathology</topic><topic>Breast Neoplasms - surgery</topic><topic>Female</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Isolated tumor cells</topic><topic>Lymph node metastases</topic><topic>Lymph Nodes - pathology</topic><topic>Lymphatic Metastasis</topic><topic>Micrometastases</topic><topic>Middle Aged</topic><topic>Neoplasm Micrometastasis - pathology</topic><topic>Neoplasm Staging</topic><topic>Predictive factors</topic><topic>Risk Assessment</topic><topic>Risk Factors</topic><topic>Sentinel Lymph Node Biopsy</topic><topic>Triple Negative Breast Neoplasms - pathology</topic><topic>Tumor Burden</topic><topic>Tumor characteristics</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Madsen, Eva V.E</creatorcontrib><creatorcontrib>Elias, Sjoerd G</creatorcontrib><creatorcontrib>van Dalen, Thijs</creatorcontrib><creatorcontrib>van Oort, Pouline M.P</creatorcontrib><creatorcontrib>van Gorp, Joost</creatorcontrib><creatorcontrib>Gobardhan, Paul D</creatorcontrib><creatorcontrib>Bongers, Vivian</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Breast (Edinburgh)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Madsen, Eva V.E</au><au>Elias, Sjoerd G</au><au>van Dalen, Thijs</au><au>van Oort, Pouline M.P</au><au>van Gorp, Joost</au><au>Gobardhan, Paul D</au><au>Bongers, Vivian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Predictive factors of isolated tumor cells and micrometastases in axillary lymph nodes in breast cancer</atitle><jtitle>Breast (Edinburgh)</jtitle><addtitle>Breast</addtitle><date>2013-10-01</date><risdate>2013</risdate><volume>22</volume><issue>5</issue><spage>748</spage><epage>752</epage><pages>748-752</pages><issn>0960-9776</issn><eissn>1532-3080</eissn><abstract>Abstract Introduction Since the introduction of the sentinel lymph node biopsy (SLNB) in patients with breast cancer, micrometastases and isolated tumor cells are detected frequently in the SLN. As such, they offer an opportunity to study the development of regional metastases in breast cancer. Patients and methods Between June 1999 and November 2010 1418 patients with cT1-2N0 breast cancer underwent SLNB. Primary tumor characteristics and information regarding regional lymph node involvement were collected prospectively. Patients were categorized into four levels of lymph node involvement: pN0, pN0(i+), pN1mi and pN ≥ 1a. An univariate analysis and a binary logistic regression analysis were performed to assess the relation between patient- and tumor characteristics and lymph node involvement. Results Increasing tumor size and younger age were associated with a higher risk of pN1mi and pN ≥ 1a and a lower chance of pN0 and pN0(i+). Triple negative molecular subtype was associated with a decreased risk of pN1mi and pN ≥ 1a. Tumor size was positively related to overall occurrence of regional lymph node metastases in a linear manner. Conclusion Patients with larger tumors, no triple negative disease, and younger age showed a decreased chance of both pN0 and pN0(i+) and an increased risk of both pN1mi and pN ≥ 1a. There seems to be a gradual shift in risk pattern from pN0 to pN0(i+) to pN1mi and to pN ≥ 1a-disease. The presence of the smallest metastases remained fairly constant over time when compared to macrometastases. This constant presence suggests that the risk of seeding and outgrowth of metastases remains constant over time.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>23313060</pmid><doi>10.1016/j.breast.2012.12.013</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0960-9776 |
ispartof | Breast (Edinburgh), 2013-10, Vol.22 (5), p.748-752 |
issn | 0960-9776 1532-3080 |
language | eng |
recordid | cdi_proquest_miscellaneous_1433516895 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Adult Age Factors Aged Aged, 80 and over Axilla Breast cancer Breast Neoplasms - pathology Breast Neoplasms - surgery Female Hematology, Oncology and Palliative Medicine Humans Isolated tumor cells Lymph node metastases Lymph Nodes - pathology Lymphatic Metastasis Micrometastases Middle Aged Neoplasm Micrometastasis - pathology Neoplasm Staging Predictive factors Risk Assessment Risk Factors Sentinel Lymph Node Biopsy Triple Negative Breast Neoplasms - pathology Tumor Burden Tumor characteristics Young Adult |
title | Predictive factors of isolated tumor cells and micrometastases in axillary lymph nodes in breast cancer |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T18%3A15%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Predictive%20factors%20of%20isolated%20tumor%20cells%20and%20micrometastases%20in%20axillary%20lymph%20nodes%20in%20breast%20cancer&rft.jtitle=Breast%20(Edinburgh)&rft.au=Madsen,%20Eva%20V.E&rft.date=2013-10-01&rft.volume=22&rft.issue=5&rft.spage=748&rft.epage=752&rft.pages=748-752&rft.issn=0960-9776&rft.eissn=1532-3080&rft_id=info:doi/10.1016/j.breast.2012.12.013&rft_dat=%3Cproquest_cross%3E1433516895%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1433516895&rft_id=info:pmid/23313060&rft_els_id=S0960977612002573&rfr_iscdi=true |